Small Bowel Dose Parameters and Acute Toxicity in Patients with Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiation
Indus Journal of Bioscience Research · 30.03.2025 · 3 (3) · 947-951
DOI: 10.70749/ijbr.v3i3.3077 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indus Journal of Bioscience Research, online erschienen am 30.03.2025. Verfasst von Simra Qureshi und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Neoadjuvant chemoradiation therapy (CRT) is the standard therapy in the treatment of the locally advanced Rectal Cancer, although acute gastrointestinal toxicity has been a significant issue because the radiation is drawn to the small bowel.
Objective
The aim of this study was to test the correlation between acute toxicity and small bowel dosimetric parameters.
Methods
It was a prospective observational study involving 72 patients with stage II-III rectal cancer undergoing neoadjuvant CRT. IMRT or VMAT was used to apply radiotherapy at a total dosage of 45-50.4 Gy plus concurrent chemotherapy. Small bowel was modeled and dose volume parameters (V15, V30, V45, Dmean, Dmax) were determined based on dose volume histograms. Acute GIT was measured weekly according to CTCAE v5.0. Predictors and threshold values were found using logistic regression and ROC curve analysis to statistically examine data.
Findings
Acute gastrointestinal toxicity was noted in 79.2% of patients and 32% of Grade ≥3 toxicity. The toxicity was significantly related to higher small bowel dose volume parameters. Patients who experienced Grade ≥2 toxicity experienced a considerably greater V15, V30, V45 and mean dose ( p 65 cc, V30 > 120 cc and Dmean > 30 Gy were found to be independent predictors of severe toxicity. Clinically relevant cut-off values with good sensitivity and specificity were found through ROC analysis.
Conclusion
The acute gastrointestinal toxicity in patients with neoadjuvant CRT rectal cancer is predicted by small bowel dosimetric parameters. With prudent treatment planning and not exceeding dose levels, treatment can become less toxic and effective.
Zitieren
APA
Qureshi, S., Uzair, M., & Fatima, M. (2025). Small Bowel Dose Parameters and Acute Toxicity in Patients with Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiation. Indus Journal of Bioscience Research, 3(3), 947-951. https://doi.org/10.70749/ijbr.v3i3.3077
Vancouver
Qureshi S, Uzair M, Fatima M. Small Bowel Dose Parameters and Acute Toxicity in Patients with Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiation. Indus Journal of Bioscience Research. 2025;3(3):947-951. doi:10.70749/ijbr.v3i3.3077
BibTeX
@article{Qureshi2025,
author = {Qureshi, Simra and Uzair, Muhammad and Fatima, Mushayyada},
title = {Small Bowel Dose Parameters and Acute Toxicity in Patients with Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiation},
journal = {Indus Journal of Bioscience Research},
year = {2025},
volume = {3},
number = {3},
pages = {947--951},
doi = {10.70749/ijbr.v3i3.3077}
}
EUVIMED